Form 4: Concentra SVP HR Granted 40,000 Restricted Shares

Danielle Kendall, Senior Vice President of Human Resources at Concentra Group Holdings Parent, Inc., was granted 40,000 shares of restricted common stock.

Summary

• Danielle Kendall, Senior Vice President of Human Resources at Concentra Group Holdings Parent, Inc. (CON), received a grant of 40,000 shares of common stock.
• The transaction occurred on November 4, 2025, with a grant price of $0 per share.
• These restricted shares will vest in equal annual installments over a four-year period.
• Following this transaction, Danielle Kendall beneficially owns 80,000 shares of common stock directly.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive is a positive sign for executive retention and alignment of interests, but it is a routine compensation event rather than a significant operational or financial announcement that would drastically alter the company's outlook.

Positives

• The grant of 40,000 restricted shares to a key executive aligns executive incentives with the company's long-term performance and shareholder value.
• A four-year vesting schedule promotes executive retention and encourages sustained contributions to the company's success.

Negatives

• The restricted stock grant does not provide immediate liquidity or cash proceeds to the executive, as the shares are subject to a vesting schedule.

Risks

• The ultimate value of the restricted stock is contingent on the future market performance of Concentra Group Holdings Parent, Inc.'s common stock.
• Unvested shares may be forfeited if the executive's employment with the company terminates before the vesting conditions are met.

Future Outlook

The grant of restricted stock with a four-year vesting schedule signals a long-term commitment to the executive and aims to align their incentives with the company's future performance and shareholder value creation.

Management Comments

• The grant of restricted stock will vest in equal annual installments over four years.

Industry Context

Executive equity grants, such as restricted stock, are a standard practice across various industries, including healthcare services, to attract, retain, and motivate key personnel. This grant to a Senior Vice President of Human Resources is consistent with typical compensation strategies aimed at aligning executive interests with long-term company success.

Comparison to Industry Standards

• The grant of restricted stock with a multi-year vesting schedule is a common executive compensation practice, comparable to equity incentive plans seen at companies like HCA Healthcare (HCA) or Tenet Healthcare (THC), which utilize similar mechanisms to incentivize long-term performance and retention.
• A $0 grant price for restricted stock is standard for equity awards that are compensation rather than a direct purchase.

Stakeholder Impact

• Shareholders: Potential positive impact through improved executive alignment with long-term company performance and retention.
• Employees: May signal stability in executive leadership and a commitment to long-term incentive programs within the company.

Next Steps

• The restricted shares will vest in equal annual installments over the next four years, commencing from November 4, 2025.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (restricted stock grant) and does not provide new material information that would significantly alter the investment thesis for Concentra Group Holdings Parent, Inc. While aligning executive incentives is positive, it is not a catalyst for a 'buy' or 'sell' recommendation based solely on this filing.

Keywords

Concentra Group Holdings Parent Inc, CON, Form 4, Restricted Stock Grant, Executive Compensation, Insider Transaction, Danielle Kendall, Equity Award